CWIG
DYN icon

Chung Wu Investment Group’s Dyne Therapeutics DYN Stock Holding History

Chung Wu Investment Group’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.4K Hold
2,000
– – 0.03% 161
2026
Q1 		$36.3K Sell
2,000
-800
-29% -$13.8K 0.03% 146
2025
Q4 		$54.8K Buy
2,800
+400
+17% +$7.58K 0.04% 130
2025
Q3 		$30.4K Buy
+2,400
New +$27.4K 0.03% 157

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Chung Wu Investment Group's DYN Position: Q2 2026 in Review

Chung Wu Investment Group held its Dyne Therapeutics (DYN) position steady in Q2 2026 at 2,000 shares worth $44.4K. The position accounts for 0.03% of the portfolio, ranked #161.

Chung Wu Investment Group first reported a position in DYN in Q3 2025 and has held it in 4 quarters since. The position peaked at $54.8K in Q4 2025. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Chung Wu Investment Group held 2,000 shares of Dyne Therapeutics worth $44.4K as of Q2 2026.
  • Chung Wu Investment Group left its Dyne Therapeutics share count unchanged in Q2 2026.
  • Dyne Therapeutics made up 0.03% of Chung Wu Investment Group's portfolio in Q2 2026, its #161 holding.
  • Chung Wu Investment Group first reported a position in Dyne Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Chung Wu Investment Group's Dyne Therapeutics position peaked at $54.8K in Q4 2025.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Chung Wu Investment Group's 13F filing for Q2 2026, filed 31 Jul 2026.